Literature DB >> 8901682

Assessing the excitable gap in reentry by resetting. Implications for tachycardia termination by premature stimuli and antiarrhythmic drugs.

H Fei1, M S Hanna, L H Frame.   

Abstract

BACKGROUND: The shortest excitable gap during reentry may determine responses to pacing and antiarrhythmic drugs. The resetting response has been used clinically to assess the excitable gap, but it cannot directly indicate the shortest excitable gap. METHODS AND
RESULTS: We studied resetting in the in vitro canine atrial tricuspid ring using an adjustable reentry preparation in which the ring was cut and reconnected electronically with an adjustable delay to vary the cycle length and excitable gap. We reset the tachycardias using 31 delays in 12 experiments. Tachycardias were terminated by premature stimuli in 16 delays. The reset window overestimated the shortest excitable gap by 25 +/- 14 ms, and the maximum degree of advancement of tachycardia underestimated the shortest excitable gap by 22 +/- 11 ms. The slope of the increasing portion of the resetting response curve was steeper in tachycardias terminated by premature stimuli than in those not terminated (-0.69 +/- 0.2 versus -0.37 +/- 0.2, P < .01). The effective refractory period difference between the sites of pacing and of block correlated with the slope of the resetting response curve. Damped cycle length oscillation after a long return cycle during resetting was always present when there was a partially excitable gap.
CONCLUSIONS: The reset window during pacing within the circuit and the maximum degree of advancement provided equally good estimates bracketing the shortest excitable gap. The slope of the resetting response curve predicted the likelihood of termination by premature stimuli. Damped cycle length oscillation after resetting detected a partially excitable gap.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901682     DOI: 10.1161/01.cir.94.9.2268

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.

Authors:  Andrew Apps; Charles Philip Miller; Sarah Fellows; Michael Jones
Journal:  BMJ Case Rep       Date:  2015-08-18

2.  Analysis of damped oscillations during reentry: a new approach to evaluate cardiac restitution.

Authors:  Adelina Munteanu; Aleksandar A Kondratyev; Jan P Kucera
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

3.  Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue.

Authors:  Zachary Laksman; Marianne Wauchop; Eric Lin; Stephanie Protze; Jeehoon Lee; Wallace Yang; Farzad Izaddoustdar; Sanam Shafaattalab; Lior Gepstein; Glen F Tibbits; Gordon Keller; Peter H Backx
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.